$ALAB

Dyckerhoff Stefan A sold $3.3M of ALAB (indirect holdings)

Dyckerhoff Stefan A sold 8,994 indirectly-held shares of Astera Labs, Inc. (ALAB) at an average of $364.35 ($364.25–$365.09, $3.28M total) across 4 trades on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dyckerhoff Stefan A
Published Jun 5, 2026, 9:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALAB
Bearish
medium confidence
Mentioned
$ALAB
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALABBearishLow
01

Why it matters

The director's sale reduces insider ownership, potentially influencing investor perception and short‑term price action.

02

Market read

Insider sales are closely watched; a $3.3M director sell can affect sentiment and trading volume.

03

What to watch

The director retains a sizable stake; the sale could be for personal liquidity rather than lack of confidence.

Relevance 5/10Novelty 6/10Timing: post‑market today

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources of material information.

Company-level read

Ticker impact

$ALABBearishMedium confidence
Context

Director Stefan Dyckerhoff sold 8,994 shares for $3.3M via a 10b5‑1 plan, reducing his stake to 5,292 shares.

Expected impact

likely downward pressure as the market prices the director's sell-off

Evidence & confidence

A $3.3M sale by a director is material for a mid‑cap chip‑fab supplier and may prompt short‑term selling.

Market effects

May raise concerns for other semiconductor suppliers as insider activity is monitored.

Limited to U.S. tech equities; no broader regional effect.

Minimal global impact beyond investors tracking Astera Labs.

Counterpoint

The sale was pre‑planned under a 10b5‑1 plan, so it may not reflect current sentiment.

Key entities

  • Astera Labs, Inc.

    U.S. listed semiconductor supplier (ticker ALAB).

  • Stefan Dyckerhoff

    Director of Astera Labs who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ALABMed

Astera Labs Stock Fell 9% in a Day as an OpenAI Revenue Report Hit Chip Stocks. Here’s Where the Stock Could Go by 2030

Astera Labs (ALAB) stock dropped 9.21% to $347.05 on October 8, following a broader chip sector sell-off triggered by OpenAI's lower-than-expected revenue report. The company launched Aries 7, its PCIe 7 signal conditioning portfolio. Despite a 23% rise in 2026 revenue forecasts to $1.91B, free cash flow fell 49.6% YoY to $67.21M, raising concerns. Analysts' target prices range from $390 to $850, with a potential total return of 146%.

$ALABMed

Why is Astera Labs stock sliding today?

Astera Labs (ALAB) stock dropped 5.0% after Zacks Research downgraded it from 'strong buy' to 'hold', following a 10% surge on S&P 500 inclusion speculation. Insider selling and high valuation also pressured the stock, with broader market declines adding to the downturn. Competitors like Marvell Technology intensify the competitive landscape. The stock remains sensitive to macroeconomic factors and analyst commentary.

$ALABHigh

Why is Astera Labs stock surging today?

Astera Labs (ALAB) stock surged 9.5% to $396.82, with traders anticipating its inclusion in the S&P 500. The company reported Q2 revenue of $392.4M, beating estimates, and guided Q3 revenue to $540M–$560M. Analysts, including Fubon, have upgraded the stock, with a $500 price target. The S&P 500 and Nasdaq each rose 0.7% today.

$ALABMed

ALAB Stock Holds Support As High Valuation Tests Traders

Astera Labs Inc. (ALAB) stock rose 6.54% due to strong AI infrastructure demand. The company reported $392.4M in quarterly revenue, $153.1M in net income, and $67.2M in free cash flow. ALAB trades at 127x earnings and 37x sales, with a strong balance sheet but high valuation concerns. Traders are watching key price levels around $262–$265 and $272–$275.

$ALABMed

ALAB Broadens Leo Portfolio: Can It Stay Ahead of MRVL & CRDO?

Astera Labs (ALAB) reported record Q2 2026 revenue growth, driven by AI connectivity products. The company expanded its Leo CXL memory controller portfolio, gaining hyperscaler traction. Q3 2026 revenue is expected between $540M and $560M. Competitors Marvell (MRVL) and Credo (CRDO) are also advancing in AI connectivity. ALAB shares rose 51.8% YTD, with a forward P/S of 16.16X.